Immunization Newsbriefs
Link to Main Page
  Back Search the Site Send Your Feedbck  
Immunization Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online
About NNii
Vaccine Information
Health Professionals
Policy Makers
Read Current Newsbriefs

Bioterror: Vaccines vs. Antidotes
USA Today; 21A
Gottlieb, Scott


A city infected with a disease by bioterrorists would need a treatment far more than a vaccine, but not many treatments exist, asserts Scott Gottlieb, a resident fellow at the American Enterprise Institute and the editor of the Gilder Biotech Report, in a USA Today commentary. The federal government is working on obtaining additional stocks of smallpox vaccine and preparing for rapid vaccinations, before symptoms develop, but Gottlieb says that the focus should be on antidotes. "There are some antiviral drugs that could effectively treat smallpox that are already on the market for other diseases, and even better drugs that could be targeted specifically to the smallpox virus," he notes. To spur the development of new antidotes, federal health officials need to tell companies what kind of drugs they want, accompanying that with a minimum bid to attract entrepreneurial enterprises. Antidotes could lessen the deaths and threats from anthrax as well as smallpox, and potential treatments exist, but without stimulation from the government, they will not be further developed, Gottlieb concludes.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.